A Study of High Dose MHAA4549A in Healthy Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This Phase 1, randomized, double-blind, placebo-controlled study will evaluate the safety, tolerability and pharmacokinetics of two, single intravenous (IV) high doses of MHAA4549A as compared to placebo when administered to healthy volunteers.
Epistemonikos ID: 9bb433ff4f2f0168179e2152f64fbf9de1701ab8
First added on: May 12, 2024